Drugs / Tucaresol
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00006209 | Jun 2000 → ? | HIV infectious disease | Aaron Diamond AIDS Research Center | Unknown | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00343941 | Nov 2004 → ? | HIV infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tucaresol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00006209 ↗ |
| Known as | 589-C | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104482 ↗ |
| Modality | Small molecule | — CHEMBL2104482 ↗ |